Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2019-10-25 Regulatory Filings
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
First patient enrolled in ALS biomarker study
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 0921R' and is dated October 25, 2019. It details an announcement by Oxford BioDynamics Plc regarding Mitsubishi Tanabe Pharma America enrolling the first patient in an ALS biomarker study utilizing OBD's technology. The text explicitly states, 'The full text of the announcement from Mitsubishi Tanabe Pharma America, Inc. is as follows:' and concludes with the standard footer information for RNS releases, including contact details for RNS and the LSE. This structure—a brief announcement referencing an external event and concluding with RNS boilerplate—is characteristic of a general regulatory news service release, which fits the 'Regulatory Filings' (RNS) category, as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action announcement (like DIV, CAP, DIRS).
2019-10-25 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and contains a notification regarding a transaction by a Director/PDMR (Stephen Diggle) involving the acquisition of Ordinary Shares. This type of insider transaction report, detailing dealings by directors and executives, directly corresponds to the definition of Director's Dealing. The presence of the RNS number and the structure suggest it is a regulatory announcement, but the specific content points precisely to 'DIRS'.
2019-09-12 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document begins with an 'RNS Number' and is dated September 10, 2019. The content explicitly details a 'PDMR Dealing' (Persons Discharging Managerial Responsibilities) transaction, specifically an acquisition of Ordinary Shares by a fund controlled by a Non-Executive Director, Stephen Diggle. This type of insider transaction disclosure, mandated under EU Market Abuse Regulation, is a specific type of regulatory filing concerning director dealings. The filing type code 'DIRS' (Director's Dealing) is the most appropriate classification for this content, as it directly reports personal share transactions by company directors.
2019-09-10 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and contains a notification regarding a 'PDMR Dealing' (Person Discharging Managerial Responsibilities Dealing). Specifically, it details the acquisition of shares by a Non-Executive Director (Stephen Diggle) and provides the required disclosure tables under the EU Market Abuse Regulation. This type of insider transaction report, when filed via the RNS system, directly corresponds to the 'Director's Dealing' category. The code for this is DIRS.
2019-09-09 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'PDMR Dealing' (Persons Discharging Managerial Responsibilities) transaction where a Non-Executive Director's associated fund purchased shares. This type of insider transaction notification, disseminated via the London Stock Exchange's RNS system, falls under the category of general regulatory announcements or insider dealing reports. Since 'Director's Dealing' (DIRS) is a specific category, and this document is a formal notification of such a dealing, DIRS is the most appropriate classification. Although it is distributed via RNS, the specific content dictates DIRS over the general RNS fallback.
2019-09-06 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and contains an announcement dated 03 September 2019 regarding a 'PDMR Dealing' (Persons Discharging Managerial Responsibilities Dealing). Specifically, it details the acquisition of Ordinary Shares by a Non-Executive Director's controlled fund. This type of insider transaction report, especially when filed via RNS (London Stock Exchange's news service), directly corresponds to the definition of Director's Dealing (DIRS). Although it is an RNS announcement, the content is highly specific to insider trading disclosure, making DIRS a more precise classification than the general RNS fallback.
2019-09-03 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.